Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim
November 29, 2022
November 2022
Escient Pharmaceuticals Announces $120 Million Series C Financing
November 28, 2022
Tenaya Therapeutics Announces Closing of Public Offering
November 21, 2022
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
November 17, 2022
Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires
November 16, 2022
Casma Therapeutics Raises $46.0 M in Series C Funding
November 15, 2022
